SCHEMBL7901229

SCHEMBL7901229

CC1CC2NC(=O)C=C[C@]2(C)[C@@H]2CC[C@]3(C)CCC[C@H]3[C@H]12

nearest known ligand 0.55

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SRD5A1 P18405 6/20 0.55
SRD5A2 P31213 6/20 0.55
CYP19A1 P11511 3/20 0.38
LMNA P02545 2/20 0.37
CYP3A4 P08684 2/20 0.37
CYP2C9 P11712 2/20 0.37
CYP2C19 P33261 2/20 0.37
ABCC4 O15439 1/20 0.37
ABCB11 O95342 1/20 0.37
ADORA3 P0DMS8 1/20 0.37
CHRM1 P11229 1/20 0.37
HSD3B1 P14060 1/20 0.37
NFKB1 P19838 1/20 0.37
MAPK1 P28482 1/20 0.37
THPO P40225 1/20 0.37
BLM P54132 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7901226 1.00 SRD5A1 (0.55) SRD5A1SRD5A2CYP19A1LMNACYP3A4
SCHEMBL9114837 0.85 SRD5A1 (0.43) SRD5A1SRD5A2CYP19A1LMNACYP3A4
SCHEMBL8135045 0.83 SRD5A1 (0.52) SRD5A1SRD5A2LMNACYP3A4CYP2C9
SCHEMBL8135928 0.83 SRD5A1 (0.52) SRD5A1SRD5A2LMNACYP3A4CYP2C9
SCHEMBL8135041 0.83 SRD5A1 (0.52) SRD5A1SRD5A2LMNACYP3A4CYP2C9
SCHEMBL9134036 0.79 SRD5A1 (0.52) SRD5A1SRD5A2LMNACYP3A4CYP2C9
SCHEMBL9134039 0.79 SRD5A1 (0.52) SRD5A1SRD5A2LMNACYP3A4CYP2C9
SCHEMBL4278336 0.79 SRD5A1 (0.66) SRD5A1SRD5A2CYP19A1LMNACYP3A4
SCHEMBL4265542 0.79 SRD5A1 (0.66) SRD5A1SRD5A2CYP19A1LMNACYP3A4
SCHEMBL4265535 0.79 SRD5A1 (0.66) SRD5A1SRD5A2CYP19A1LMNACYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6187925-B1 TREATING IODINATED AZASTEROID WITH POTASSIUM TERT-BUTOXIDE, ISOLATING ENE STEROID MERCK & CO., INC. 2001-02-13 US disclosed
EP-1042356-A2 INTERMEDIATES AND PROCESS FOR THE SYNTHESIS OF 17-UNSUBSTITUTED 16.BETA.-ARYLOXY 4-AZASTEROIDS Merck & Co., Inc. (US) 2000-10-11 EP disclosed
WO-1999032507-A2 INTERMEDIATES AND PROCESS FOR THE SYNTHESIS OF 17-UNSUBSTITUTED 16.BETA.-ARYLOXY 4-AZASTEROIDS MERCK & CO., INC. (US) 1999-07-01 WO disclosed
EP-0862556-A4 17-ALKYL-7-SUBSTITUTED-4-AZA STEROID DERIVATIVES MERCK & CO INC (US) 1999-02-03 EP disclosed
EP-0862556-A1 17-ALKYL-7-SUBSTITUTED-4-AZA STEROID DERIVATIVES Merck & Co., Inc. (US) 1998-09-09 EP disclosed
WO-1998009632-A1 METHODS AND COMPOSITIONS FOR TREATING PRETERM LABOR MERCK & CO., INC. (US) 1998-03-12 WO disclosed
WO-1997015558-A1 17-ALKYL-7-SUBSTITUTED-4-AZA STEROID DERIVATIVES MERCK & CO., INC. (US) 1997-05-01 WO disclosed